Medicinal product name Evra
Pharmaceutical form Transdermal patch
Strength 203 mcg + 33.9 mcg/24 h 
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code G03AA13 Sex hormones and modulators of the genital system

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N9
(6 mg/600 µg)
Bag    EU/1/02/223/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/02/223/002
Date of authorisation Aug 22, 2002
Marketing authorisation holder, country Gedeon Richter Plc., Hungary